$2.53T
Total marketcap
$191.06B
Total volume
BTC 50.00%     ETH 15.86%
Dominance

Immunovant IMVT Stock

30.27 USD {{ price }} -0.851622% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
4.4B USD
LOW - HIGH [24H]
30 - 30.8 USD
VOLUME [24H]
988.08K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.81 USD

Immunovant Price Chart

Immunovant IMVT Financial and Trading Overview

Immunovant stock price 30.27 USD
Previous Close 21.29 USD
Open 21.24 USD
Bid 0 USD x 800
Ask 0 USD x 1000
Day's Range 20.94 - 21.37 USD
52 Week Range 3.4 - 24.18 USD
Volume 788.79K USD
Avg. Volume 1.04M USD
Market Cap 2.76B USD
Beta (5Y Monthly) 1.006844
PE Ratio (TTM) N/A
EPS (TTM) -1.81 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 28.23 USD

IMVT Valuation Measures

Enterprise Value 2.4B USD
Trailing P/E N/A
Forward P/E -11.062827
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 7.597986
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -11.539

Trading Information

Immunovant Stock Price History

Beta (5Y Monthly) 1.006844
52-Week Change 488.57%
S&P500 52-Week Change 20.43%
52 Week High 24.18 USD
52 Week Low 3.4 USD
50-Day Moving Average 18.62 USD
200-Day Moving Average 14.73 USD

IMVT Share Statistics

Avg. Volume (3 month) 1.04M USD
Avg. Daily Volume (10-Days) 936.23K USD
Shares Outstanding 130.41M
Float 48.42M
Short Ratio 2.76
% Held by Insiders 58.66%
% Held by Institutions 43.87%
Shares Short 3.43M
Short % of Float 6.12%
Short % of Shares Outstanding 2.63%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -28.25%
Return on Equity (ttm) -50.69%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -208083008 USD
Net Income Avi to Common (ttm) -210960000 USD
Diluted EPS (ttm) -1.67
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 376.53M USD
Total Cash Per Share (mrq) 2.89 USD
Total Debt (mrq) 1.22M USD
Total Debt/Equity (mrq) 0.34 USD
Current Ratio (mrq) 9.339
Book Value Per Share (mrq) 2.781

Cash Flow Statement

Operating Cash Flow (ttm) -188192992 USD
Levered Free Cash Flow (ttm) -107818496 USD

Profile of Immunovant

Country United States
State NY
City New York
Address 320 West 37th Street
ZIP 10018
Phone 917 580 3099
Website https://immunovant.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 164

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Q&A For Immunovant Stock

What is a current IMVT stock price?

Immunovant IMVT stock price today per share is 30.27 USD.

How to purchase Immunovant stock?

You can buy IMVT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Immunovant?

The stock symbol or ticker of Immunovant is IMVT.

Which industry does the Immunovant company belong to?

The Immunovant industry is Biotechnology.

How many shares does Immunovant have in circulation?

The max supply of Immunovant shares is 145.29M.

What is Immunovant Price to Earnings Ratio (PE Ratio)?

Immunovant PE Ratio is now.

What was Immunovant earnings per share over the trailing 12 months (TTM)?

Immunovant EPS is -1.81 USD over the trailing 12 months.

Which sector does the Immunovant company belong to?

The Immunovant sector is Healthcare.

Immunovant IMVT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Capital Market Composite RCMP 116.84 USD
-0.68
116.47 USD 117.72 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Other Finance OFIN 11402.83 USD
+0.16
11383.66 USD 11445.94 USD